Zovighian Bernard J's Form 4 filing
Edwards Lifesciences Corp (EW) · filed Jul 27, 2026
- Accession no.
- 0001225208-26-006743
- Filed
- Jul 27, 2026, 6:59 PM ET
- Trade date
- Jul 27, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $245.1K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Zovighian Bernard JCIK 0001665141 | Director, Officer (CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 27, 2026 | Common Stock | GGiftDisposed | −319.6499 | $0.00 | $0 | 98,845 | Direct | |
| Jul 27, 2026 | Common Stock | GGiftAcquired | +319.6499 | $0.00 | $0 | 11,836.201 | Indirect | |
| Jul 27, 2026 | Common Stock | SSaleDisposed | −2,920.5511 | $83.93 | −$245,134.12 | 8,915.6499 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.